Background |
Number |
References |
1.1 Rationale for choosing a consensus method over other methods |
4 |
12 25 27 28
|
1.2 Clearly defined objective |
6 |
12 17 18 20 27 28
|
Methods |
|
|
2.1 Review of existing evidence informing consensus study |
5 |
20 21 27 28 31
|
2.2 Inclusion and exclusion criteria of the literature search |
3 |
17 20 22
|
2.3 Composition of the panel |
16 |
12 16–23 25–30 32
|
2.4 Public patient involvement (PPI) |
0 |
|
2.5 Panel recruitment |
4 |
12 17 22 23
|
2.6 Defining consensus and the threshold for achieving consensus |
13 |
12 17–21 23–29
|
2.7 Decision of item approval |
3 |
12 17 27
|
2.8 Number of voting rounds |
10 |
12 16 18 20 21 23 26–28 32
|
2.9 Rationale for number of voting rounds |
8 |
16 20–23 25 26 28
|
2.10 Time between voting rounds |
1 |
17
|
2.11 Additional methods used alongside consensus |
2 |
17 23
|
2.12 Software or tools used for voting |
1 |
25
|
2.13 Anonymity of panellists and how this was maintained |
7 |
16 20–22 25 28 29
|
2.14 Feedback to panellists at the end of each round |
11 |
17 19–22 25–29 31
|
2.15 Synthesis/analysis of responses after voting rounds |
5 |
12 22–24 30
|
2.16 Pilot testing of study material/instruments |
3 |
12 22 28
|
2.17 Role of the steering committee/chair/co-chair/facilitator |
0 |
|
2.18 Conflict of interest or funding received |
4 |
12 29 30 32
|
2.19 Measures to avoid influence by conflict of interest |
1 |
12
|
Results |
|
|
3.1 Results of the literature search |
1 |
12
|
3.2 Number of studies found as supporting evidence |
0 |
|
3.3 Response rates per voting round |
5 |
12 21 22 25 30
|
3.4 Results shared with respondents |
9 |
12 17 20 25–28 30 31
|
3.5 Dropped items |
5 |
12 16 18 26 32
|
3.6 Collection, synthesis and comments from panellists |
5 |
12 17 22 28 31
|
3.7 Final list of items (eg, for guideline or reporting guideline) |
4 |
12 22 30 31
|
Discussion |
|
|
4.1 Limitations and strengths of the study |
5 |
12 20 25 27 28
|
4.2 Applicability, generalisability, reproducibility |
3 |
12 17 26
|